|
US20030138438A1
(en)
|
1998-03-18 |
2003-07-24 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US20030236209A1
(en)
|
1998-03-18 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US6436703B1
(en)
*
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
EP1317275A1
(de)
|
2000-09-06 |
2003-06-11 |
Müller, Friederike |
Arzneimittel mit einer für das rna-bindende koc-protein kodierenden dna-sequenz, einem koc-protein oder einer dna-sequenz des koc-promotors
|
|
US7919467B2
(en)
|
2000-12-04 |
2011-04-05 |
Immunotope, Inc. |
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
|
SI2113253T1
(sl)
|
2008-04-30 |
2010-06-30 |
Immatics Biotechnologies Gmbh |
Nove formulacije s tumorjem povezanih peptidov ki se vežejo na molekule humanega levkocitnega antigena HLA razreda I ali II za cepiva
|
|
US20100037514A1
(en)
|
2008-05-13 |
2010-02-18 |
Afton Chemical Corporation |
Fuel additives to maintain optimum injector performance
|
|
PL2119726T5
(pl)
*
|
2008-05-14 |
2018-04-30 |
Immatics Biotechnologies Gmbh |
Nowe i silne peptydy MHC klasy II pochodzące z surwiwiny i neurokanu
|
|
PL2172211T3
(pl)
*
|
2008-10-01 |
2015-05-29 |
Immatics Biotechnologies Gmbh |
Kompozycja związanych z guzem peptydów i związana z tym szczepionka przeciwrakowa do leczenia glejaka (GBM) i innych rodzajów raka
|
|
US8253536B2
(en)
|
2009-04-22 |
2012-08-28 |
Simon Fraser University |
Security document with electroactive polymer power source and nano-optical display
|
|
TW201124530A
(en)
|
2009-12-01 |
2011-07-16 |
Oncotherapy Science Inc |
IMP-3 oligopeptides and vaccines including the same
|
|
CA2793383A1
(en)
|
2010-03-16 |
2011-09-22 |
Adapta Medical, Inc. |
Catheter reservoir seals
|
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201015765D0
(en)
|
2010-09-21 |
2010-10-27 |
Immatics Biotechnologies Gmbh |
Use of myeloid cell biomarkers for the diagnosis of cancer
|
|
DK2633020T3
(da)
|
2010-10-25 |
2019-08-19 |
Stepan Co |
Tøjvaskemidler baseret på sammensætninger afledt af naturlig oliemetatese
|
|
GB201021289D0
(en)
|
2010-12-15 |
2011-01-26 |
Immatics Biotechnologies Gmbh |
Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer
|
|
JP5828909B2
(ja)
|
2011-01-10 |
2015-12-09 |
シーティー アトランティック リミテッド |
腫瘍関連抗原結合抗体を含む併用療法
|
|
US10279018B2
(en)
|
2012-12-03 |
2019-05-07 |
Unity Biotechnology, Inc. |
Immunogenic compositions for inducing an immune response for elimination of senescent cells
|
|
WO2014088432A1
(en)
|
2012-12-06 |
2014-06-12 |
Callaghan Innovation Research Limited |
Conjugate compounds
|
|
CN105431524B
(zh)
|
2013-06-10 |
2020-04-21 |
达娜-法勃肿瘤研究所公司 |
用于降低肿瘤细胞的免疫抑制的方法和组合物
|
|
GB201319446D0
(en)
*
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
EA035259B1
(ru)
|
2014-02-14 |
2020-05-21 |
Иммьюн Дизайн Корп. |
Иммунотерапия рака с применением комбинации местной и системной иммунной стимуляции
|
|
EP3320916B1
(en)
|
2014-03-17 |
2021-09-15 |
BUNDESREPUBLIK DEUTSCHLAND letztvertreten durch das Robert Koch-Institut vertreten durch seinen Präsidenten |
A medicament for use in a method of inducing or extending a cellular cytotoxic immune response
|
|
JP2015227292A
(ja)
|
2014-05-30 |
2015-12-17 |
国立大学法人高知大学 |
膵がん細胞浸潤転移抑制ワクチン
|
|
US10046046B2
(en)
|
2014-06-05 |
2018-08-14 |
Victoria Link Limited |
Amino sphingoglycolipid analogues
|
|
GB201504502D0
(en)
|
2015-03-17 |
2015-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
|
|
GB201505305D0
(en)
*
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
DK3388075T5
(da)
*
|
2015-03-27 |
2024-09-23 |
Immatics Biotechnologies Gmbh |
Hidtil ukendte peptider og kombination af peptider til anvendelse ved immunterapi mod forskellige tumorer
|
|
GB201505585D0
(en)
*
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
|
GB201507030D0
(en)
*
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
PH12021550910A1
(en)
*
|
2015-05-06 |
2022-03-07 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers
|
|
JP2018518956A
(ja)
*
|
2015-06-19 |
2018-07-19 |
イマティクス バイオテクノロジーズ ゲーエムベーハー |
免疫療法で使用するための新規ペプチドおよびペプチド組み合わせおよび膵臓がんおよびその他のがんに対して使用するためにスキャフォールドを作製する方法
|
|
GB201510771D0
(en)
*
|
2015-06-19 |
2015-08-05 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
|
|
GB201511546D0
(en)
*
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
HRP20202019T1
(hr)
*
|
2015-07-01 |
2021-04-30 |
Immatics Biotechnologies Gmbh |
Novi peptidi i kombinacija peptida za uporabu u imunoterapiji protiv raka jajnika i drugih malignih tumora
|
|
GB201521746D0
(en)
*
|
2015-12-10 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
|
|
DK3430037T3
(da)
*
|
2016-03-16 |
2022-11-21 |
Immatics Biotechnologies Gmbh |
Transficerede t-celler og t-cellereceptorer til anvendelse i immunterapi mod cancere
|
|
GB201604494D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Transfected T-Cells and T-Cell receptors for use in immunotherapy against cancers
|
|
GB201604490D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides combination of peptides for use in immunotherapy against cancers
|
|
EA201892159A1
(ru)
|
2016-04-06 |
2019-03-29 |
Имматикс Байотекнолоджиз Гмбх |
Новые пептиды и комбинации пептидов для применения в иммунотерапии омл и других видов рака
|
|
GB201609193D0
(en)
|
2016-05-25 |
2016-07-06 |
Immatics Biotechnologies Gmbh |
Novel peptides, combination of peptides as targets for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
|
|
TW202304970A
(zh)
|
2016-08-26 |
2023-02-01 |
德商英麥提克生物技術股份有限公司 |
用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架
|
|
BR112019028280A2
(pt)
|
2017-07-04 |
2020-07-14 |
Curevac Ag |
moléculas de ácido nucleico
|
|
WO2019051001A1
(en)
|
2017-09-06 |
2019-03-14 |
California Institute Of Technology |
SIGNALING AND BIFUNCTIONAL RECEPTORS HAVING ANTIGENS (SABR)
|
|
WO2020072700A1
(en)
|
2018-10-02 |
2020-04-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
|
JP2022096002A
(ja)
|
2019-04-25 |
2022-06-29 |
三洋化成工業株式会社 |
アルカリ電池用ゲル化剤及びアルカリ電池
|
|
AU2020356334A1
(en)
|
2019-09-24 |
2022-03-31 |
Université Catholique de Louvain |
Modified vesicular stomatitis virus glycoprotein and uses thereof for the treatment of brain tumors
|
|
US12394502B2
(en)
|
2019-10-02 |
2025-08-19 |
The General Hospital Corporation |
Method for predicting HLA-binding peptides using protein structural features
|